Evidence map›Paper›PMID 20559035›Full record

ArticleAIDS (London, England)2010

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.

Mark A Wallet, Carina A Rodriguez, Li Yin, Sara Saporta, Sasawan Chinratanapisit, Wei Hou, John W Sleasman, Maureen M Goodenow

Abstract read
In one paragraph

Article in AIDS (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Cardiovascular Disease and Thrombosis in HIV Infection.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mark A WalletDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, USA.
Carina A Rodriguez
Li Yin
Sara Saporta
Sasawan Chinratanapisit
Wei Hou
John W Sleasman
Maureen M Goodenow
University of Florida · US

Funding

IMPACT OF HIV-1 GENOTYPE ON THERAPY RESPONSE IN CHILDRENR01AI047723 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI SLEASMAN, JOHN W. · 2001 to 2010
$3.3M
HIV-1 VARIANTS WITHIN PBMC SUBPOPULATIONS IN INFANTSR01HD032259 · NICHD · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1995 to 2007
$2.8M
IMMUNOLOGIC/GENETIC MECHANISMS IN RHEUMATIC DISEASEST32AR007603 · NIAMS · UNIVERSITY OF FLORIDA · PI REEVES, WESTLEY H · 1998 to 2014
$2.2M
Role of HIV-1 Env Diversity in Cellular TropismR01AI065265 · NIAID · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 2005 to 2009
$2.1M
HIV 1 VARIANTS WITHIN PBMC SUBPOPULATIONS IN INFANTSR55HD032259 · NICHD · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1994 to 1994
–
NIAID NIH HHS AI047723NIAID NIH HHS AI065265NIAID NIH HHS R01 AI047723NIAID NIH HHS R01 AI065265NIAMS NIH HHS T32 AR007603NICHD NIH HHS HD032259NICHD NIH HHS R01 HD032259
6 · The paper itself

Abstract

objectiveHIV-1 replication and microbial translocation occur concomitant with systemic immune activation. This study delineates mechanisms of immune activation and CD4 T-cell decline in pediatric HIV-1 infection.

designCross-sectional and longitudinal cellular and soluble plasma markers for inflammation were evaluated in 14 healthy and 33 perinatally HIV-1-infected pediatric study volunteers prior to and over 96 weeks of protease-inhibitor-containing combination antiretroviral therapy (ART). All HIV-1-infected patients reconstituted CD4 T cells either with suppression of viremia or rebound of drug-resistant virus.

methodsSystemic immune activation was determined by polychromatic flow cytometry of blood lymphocytes and ELISA for plasma soluble CD27, soluble CD14, and tumor necrosis factor. Microbial translocation was evaluated by limulus amebocyte lysate assay to detect bacterial lipopolysaccharide (LPS) and ELISA for antiendotoxin core antigen immunoglobulin M (IgM) antibodies. Immune activation markers were compared with viral load, CD4 cell percentage, and LPS by regression models. Comparisons between healthy and HIV-1-infected or between different viral outcome groups were performed by nonparametric rank sum.

resultsMicrobial translocation was detected in healthy infants but resolved with age (P < 0.05). LPS and soluble CD14 levels were elevated in all HIV-1-infected patients (P < 0.05 and P < 0.0001, respectively) and persisted even if CD4 T cells were fully reconstituted, virus optimally suppressed, and lymphocyte activation resolved by ART. Children with CD4 T-cell reconstitution but viral rebound following ART continued to display high levels of soluble CD27.

conclusionMicrobial translocation in pediatric HIV-1 infection is associated with persistent monocyte/macrophage activation independent of viral replication or T-cell activation.

Indexed as

Bacterial TranslocationAdolescentAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountChildChild, PreschoolCross-Sectional StudiesFemaleHIV-1HIV InfectionsHumansInfantLipopolysaccharide ReceptorsMacrophage ActivationMaleTumor Necrosis Factor-alphaLipopolysaccharide ReceptorsTumor Necrosis Factor-alphaTumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID20559035
PMCPMC2888494
OpenAlexW1969385194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.